Akshay S Thomas
Overview
Explore the profile of Akshay S Thomas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arepalli S, Kopplin L, Tsui E, Brill D, Sobrin L, Papaliodis G, et al.
Retina
. 2025 Jan;
PMID: 39841907
Purpose: To describe the patterns of ocular inflammation following COVID-19 vaccination, assess underlying commonalities and understand outcomes. Methods: Retrospective, multicenter cohort study, conducted between 2020 and 2021. Patients with no...
2.
Kundu A, Thomas A, Mirzania D, Kim J, Stinnett S, Fekrat S
J Vitreoretin Dis
. 2024 Jan;
8(1):51-57.
PMID: 38223779
To compare the risk factors and clinical outcomes in patients younger than 50 years with acute, treatment-naïve branch retinal vein occlusion (BRVO) with outcomes in patients 50 years or older....
3.
Zheng Y, Woodward R, Feng H, Lee T, Zhang X, Pant P, et al.
Retina
. 2023 Sep;
44(1):159-165.
PMID: 37683266
Background/purpose: To evaluate the status of the posterior vitreous hyaloid on presenting optical coherence tomography images of the macula and its relationship to clinical characteristics, treatment patterns, and outcomes in...
4.
Zaki A, Pasadhika S, Huang J, Thomas A, Burkholder B, Lim L, et al.
Eye (Lond)
. 2023 Aug;
38(2):386-392.
PMID: 37598261
Background: Autoimmunity and deficiency of the transcription factor autoimmune regulator protein (AIRE) are known associations with Down syndrome (DS). Lack of AIRE abrogates thymic tolerance. The autoimmune eye disease associated...
5.
Pant P, Kundu A, Rathinavelu J, Wei X, Agrawal R, Stinnett S, et al.
Ophthalmol Ther
. 2023 May;
12(4):2103-2115.
PMID: 37221425
Introduction: Cystoid macular edema (CME) is the most common cause of central vision loss in eyes with branch retinal vein occlusion (BRVO eyes). In recent literature, choroidal vascularity index (CVI)...
6.
Therapeutic Outcomes of Non-Infectious Scleritis Treated with Tumor Necrosis Factor-Alpha Inhibitors
Brown J, Thomas A, Armbrust K, Boyd K, Berkenstock M, Kopplin L
Ocul Immunol Inflamm
. 2023 Apr;
32(6):1017-1023.
PMID: 37043601
Purpose: We determine the efficacy of tumor necrosis factor-α (TNF) inhibitors in establishing scleritis quiescence. Methods: We conducted a multicenter retrospective chart review of patients with non-infectious scleritis treated with...
7.
Stallworth J, Thomas A, Constantine R, Stinnett S, Fekrat S
J Vitreoretin Dis
. 2023 Apr;
4(1):13-21.
PMID: 37009559
Purpose: This article describes treatment patterns and visual outcomes for central retinal vein occlusion (CRVO) in the antivascular endothelial growth factor (anti-VEGF) era. Methods: A retrospective cohort study of eyes...
8.
Lee T, Robbins C, Thomas A, Fekrat S
J Vitreoretin Dis
. 2023 Apr;
5(5):412-419.
PMID: 37008715
Purpose: This work aims to investigate real-world treatment patterns and outcomes in eyes with branch retinal vein occlusion in the antivascular endothelial growth factor (anti-VEGF) era. Methods: A retrospective, nonrandomized,...
9.
Thomas G, Kiew S, Singh P, Dmitriev P, Thomas A, Fekrat S
J Vitreoretin Dis
. 2023 Apr;
6(2):97-103.
PMID: 37008668
Purpose: This work evaluates the effect of antiplatelet and anticoagulant agents on clinical outcomes, optical coherence tomography (OCT) parameters, and macular ischemia in eyes with central retinal vein occlusion (CRVO)....
10.
Kiew S, Thomas G, Thomas A, Fekrat S
J Vitreoretin Dis
. 2023 Apr;
4(3):186-191.
PMID: 37007449
Purpose: This article studies whether the characteristics and clinical course of African American patients with central retinal vein occlusion (CRVO) differ from other racial groups. Methods: This retrospective cohort study...